Gene Transfer with Etranacogene dezaparvovec (AAV5-Padua hFIX variant) in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial

Authors
Category Primary study
JournalHamostaseologie
Year 2021
This article has no abstract
Epistemonikos ID: 1252045b52a9a3f4c00e993e9d0997d528822082
First added on: Feb 14, 2025